Giridhar Kanuri

Jena, TH 07743, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation.

Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation.

Journal: The British journal of nutrition

Published: November 24, 2016

Beer Is Less Harmful for the Liver than Plain Ethanol: Studies in Male Mice Using a Binge-Drinking Model.

Beer Is Less Harmful for the Liver than Plain Ethanol: Studies in Male Mice Using a Binge-Drinking Model.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire)

Published: February 12, 2015

Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice.

Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice.

Journal: European journal of nutrition

Published: November 05, 2014

Effect of acute beer ingestion on the liver: studies in female mice.

Effect of acute beer ingestion on the liver: studies in female mice.

Journal: European journal of nutrition

Published: November 19, 2013

Sex-specific differences in the development of acute alcohol-induced liver steatosis in mice.

Sex-specific differences in the development of acute alcohol-induced liver steatosis in mice.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire)

Published: August 24, 2013

Oral intake of chicoric acid reduces acute alcohol-induced hepatic steatosis in mice.

Oral intake of chicoric acid reduces acute alcohol-induced hepatic steatosis in mice.

Journal: Nutrition (Burbank, Los Angeles County, Calif.)

Published: May 14, 2013

In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD).

In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD).

Journal: International journal of molecular sciences

Published: March 19, 2013

Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease.

Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 05, 2012

Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.

Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.

Journal: Molecular medicine (Cambridge, Mass.)

Published: May 19, 2012

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: April 25, 2012

Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.

Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.

Journal: The British journal of nutrition

Published: October 25, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026